Mar 22, 2020
in Alimentary Pharmacology and Therapeutics
Background Few data exist to select a second biologic agent in patients with refractory ulcerative colitis (UC). Aim To compare the efficacy of infliximab (IFX) and vedolizumab (VDZ) in UC patients who failed a first subcutaneous anti‐tumor necrosing factor (TNF) agent.
Method Consecutive UC patients from 12 French centres starting IFX or VDZ after at least one injection of adalimumab or goli...
Cancers, Vol. 15, Pages 590: Efficacy of Organ Preservation Strategy by Adjuvant Chemoradiotherapy after Non Curative Endoscopic Resection for Superficial SCC: A Multicenter Western Study Cancers doi: 10.3390/cancers15030590 Authors: Arthur Berger Guillaume Perrod Mathieu Pioche Maximilien Barret Elodie Cesbron Métivier Vincent Lépilliez Marianne Hupé Enrique Perez Cuadrado Robles Franck Cholet Au...